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Background: More than 15,000 marine products have been described up to now; Sponges are champion
producers, concerning the diversity of products that have been found. Most bioactive compounds from sponges
were classified into anti-inflammatory, antitumor, immuno- or neurosurpressive, antiviral, antimalarial, antibiotic, or
antifouling. Evaluation of in vitro inhibitory effects of different extracts from four marine sponges versus some
antioxidants indices and carbohydrate hydrolyzing enzymes concerned with diabetes mellitus was studied. The
chemical characterizations for the extracts of the predominating sponges; SP1 and SP3 were discussed.
Methods: All chemicals served in the biological study were of analytical grade and purchased from Sigma, Merck
and Aldrich. All kits were the products of Biosystems (Spain), Sigma Chemical Company (USA), Biodiagnostic (Egypt).
Carbohydrate metabolizing enzymes; α-amylase, α-glucosidase, and β-galactosidase (EC3.2.1.1, EC3.2.1.20, and
EC3.2.1.23, respectively) were obtained from Sigma Chemical Company (USA).
Results: Four marine sponges; Smenospongia (SP1), Callyspongia (SP2), Niphates (SP3), and Stylissa (SP4), were
collected from the Red Sea at Egyptian coasts, and taxonomically characterized. The sponges’ extracts exhibited
diverse inhibitory effects on oxidative stress indices and carbohydrate hydrolyzing enzymes in linear relationships to
some extent with concentration of inhibitors (dose dependant). The extracts of sponges (3, 1, and 2) showed,
respectively, potent-reducing power. Purification and Chemical characterization of sponge 1 using NMR and mass
spectroscopy, recognized the existence of di-isobutyl phthalate (1), di-n-butyl phthalate (2), linoleic acid (3), β-
sitosterol (4), and cholesterol (5). Sponge 3 produced bis-[2-ethyl]-hexyl-phthylester (6) and triglyceride fatty acid
ester (7).
Conclusion: Marine sponges are promising sources for delivering of bioactive compounds. Four marine sponges,
collected from Red Sea at Egyptian coasts, were identified as Smenospongia (SP1), Callyspongia (SP2), Niphates
(SP3), and Stylissa (SP4). The results demonstrated that different sponges extracts exhibited inhibitory effects on
oxidative stress indices and carbohydrate hydrolyzing enzymes in linear relationships to some extent with
concentration of inhibitors (dose dependant). The extracts of sponges (3, 1, and 2) showed, respectively, potent-
reducing power. Chemical characterizations of sponges SP1 and SP3 were discussed. Based on this study, marine
sponges are considered as talented sources for production of diverse and multiple biologically active compounds.
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Pharmaceutical interest in sponges was aroused in the
early 1950s by the discovery of a number of unknown
nucleosides: spongothymidine and spongouridine in the
marine sponge Cryptotethia crypta [1,2]. These nucleo-
sides were the basis for the synthesis of Ara-C, the first
marine-derived anticancer agent and the antiviral drug
Ara-A [3]. Ara-C is currently used in the routine treat-
ment of patients with leukaemia and lymphoma. More
than 15,000 marine products have been described up to
now [4,5]; Sponges are champion producers, concerning
the diversity of products that have been found [6]. They
are responsible for more than 5,300 different products
and every year hundreds of new compounds are being dis-
covered [4]. Most bioactive compounds from sponges can
be classified as anti-inflammatory, antitumor, immuno- or
neurosurpressive, antiviral, antimalarial, antibiotic, or anti-
fouling [5-9].
Exogenous chemical and endogenous metabolic pro-
cesses in the human body or in the digestive system
might produce highly reactive free radicals, especially
oxygen-derived radicals, which are capable of oxidizing
biomolecules, resulting in cell death and tissue damage.
Almost all organisms are well protected against free rad-
ical damage by anti-oxidative enzymes such as super-
oxide dismutase and catalase (CAT), or by chemicals
such as carotenoids, polyphenols, and glutathione [10].
However, when the process of antioxidant protection
becomes unbalanced, deterioration of physiological func-
tions may occur resulting in diseases and accelerated
aging. There is an increasing evidence, indicating that
reactive oxygen species and free radical-mediated reac-
tions are involved in degenerative or pathological events
such as aging, cancer, coronary heart ailments, and
Alzheimer’s diseases [11]. Moreover, the suppression of
the oxidative stress and inflammatory were responded
through the inhibition of tumor necrosis factor
β-(TNF-β) signaling [12]. Natural triterpenes isolated
from different marine sponges inhibited iNOS expres-
sion and the activation of NF-β, while polyketides
showed antitumoural activity [13]. Most screenings of
secondary metabolites of biomedical importance from
marine sponge extracts reported an inhibitory effects
that turned out to be have strongly cytotoxic effects
[14,15].
In this article, evaluation of in vitro inhibitory effects
of different extracts from four marine sponges Smenos-
pongia (SP1), Callyspongia (SP2), Niphates (SP3), and
Stylissa (SP4) versus some antioxidants indices and
carbohydrate hydrolyzing enzymes concerned with dia-
betes mellitus. The studied sponges were collected from
Red Sea, Hurghada, at Egyptian coasts. Alternatively, the
chemical characterizations for two extracts of the pre-
dominating sponges; SP1 and SP3 were discussed on thebases of different chromatographic and spectroscopic
means. In accordance, di-isobutyl phthalate (1), di-n-
butyl phthalate (2), linoleic acid (3), β-sitosterol (4), and
cholesterol (5) were obtained from SP1; while SP3 deliv-
ered bis-[2-ethyl]-hexyl-phthylester (6) and triglyceride
fatty acid ester (7).
Methods
Four marine sponges belonging to the genus Smenospon-
gia (SP1), Callyspongia (SP2), Niphates (SP3) and Sty-
lissa (SP4) were collected from Hurghada at El-Gouna
and Shaa’b south Giffton island at depth of 5–8 m. Mor-
phologically, the sponges were characterized and speci-
mens of them were deposited at Red Sea Marine parks,
P.O. Box 363-Hurgada, Red Sea, Egypt.
The four sponges were individually extracted by
DCM–MeOH (2:1), followed by filtration, and the
afforded DCM layers were extracted and evaporated in
vacuo to dryness. Extracts of sponges were applied to a
series of chromatographic purifications including Flash
chromatography on silica gel (230–400 mesh), Size ex-
clusion chromatography was done on Sephadex LH-20,
and PTLC to isolate their produced bioactive compounds
in pure forms. Purity of the yielded compounds were
monitored by Rf values were measured on Polygram SIL
G/UV254 TLC cards. This lead to isolate the following
compounds; Linoleic acid; (9Z,12Z)-9, 12-octadecanoic
acid (3), β-sitosterol (4), Cholesterol (5), Di-(2-ethyl-
hexyl)phthalate(DEHP)(6), and Triglyceride fatty acids
mixture (7) were assigned with the aid of different spec-
troscopic means as follows; NMR (1 H &13 C NMR) was
served using Varian Unity 300 (300.145 MHz; and Varian
Inova 600 (150.820 MHz) spectrometers. ESI MS
(Thermo Finnigan LCQ with quaternary pump Rheos
4000 (Flux Instrument); Thermo Scientific, USA). EI MS
(a Finnigan MAT 95 spectrometer (70 eV); Thermo Sci-
entific, USA. GC-MS was measured on a Trace GC-MS
Thermo Finnigan chromatograph, ionization mode EI
(70 eV).
The in vitro antioxidant study of the sponges extracts
were carried out using Carbohydrate metabolizing
enzymes; α-amylase, α-glucosidase, and β-galactosidase.
The antioxidant scavenging activity was studied using
serial concentrations of different sponge extracts
(10:1000 μg/mL) versus DPPH-free radical. The NO-free
radical scavenging activity of extracts was determined
according to the method of Sreejayan and Rao [16].
Results and discussion
Chemical characterization
Extracts of the four marine sponges Smenospongia (SP1),
Callyspongia (SP2), Niphates (SP3), and Stylissa (SP4)
were applied to a series of chromatographic applications,
and hence to identify their bioactive constituents
Table 1 DPPH inhibition percent of the four sponges extracts
Concentrations Extracts of the four sponges
SP1 SP2 SP3 SP4
10 μg/mL 10.85 ± 5.42c 47.7 ± 0.84e 26.31 ± 0.50d 16.39 ± 4.63d
50 μg/mL 10.77 ± 2.09c 60.53 ± 0.50d 26.00 ± 1.38d 22.38 ± 1.23c
100 μg/mL 18.09 ± 1.13b 66.45 ± 0.29c 34.04 ± 0.94c 32.54 ± 2.14b
500 μg/mL 22.81 ± 1.81b 69.52 ± 0.97b 37.39 ± 1.10b 35.94 ± 1.42ab
1000 μg/mL 30.64 ± 0.60a 72.19 ± 0.69a 40.17 ± 0.9a 38.48 ± 0.70a
LSD 5% 5.06 1.26 1.83 4.46
DPPH is expressed %; Data are mean ± SD of 3 replicates; Statistical analysis is carried out using one way analysis of variance (ANOVA) using CoStat: computer
program; unshared superscript letters between treatments are significance values at P < 0.001.
Shaaban et al. Organic and Medicinal Chemistry Letters 2012, 2:30 Page 3 of 12
http://www.orgmedchemlett.com/content/2/1/30chemically using diverse spectroscopic means. Both
sponges, SP1 and SP3, were intensively studied. Five
compounds were revealed from SP1; di-isobutyl phthal-
ate (1), di-n-butyl phthalate (2), linoleic acid (3), β-sitos-
terol (4), and cholesterol (5). The first two esters, di-
isobutyl phthalate (1, RT: 13.79, 100%) and di-n-butyl
phthalate (2, RT: 14.84, 12%), were established by GC-
MS analysis together with further unknown components
of RT 19.03 (17%) and 20.01 (78%). Purification of
sponge 3 (SP3) afforded bis-[2-ethyl]-hexyl-phthylester
(6) and triglyceride fatty acid ester (7). In contrast, work-
ing up and purification of the extracts obtained from the
remaining two sponges SP2 and SP4 delivered multi-
metabolites, however, with insufficient amounts for
analysis.
Based on their chromatographic properties, spectro-
scopic means (NMR and MS), and comparison with au-
thentic samples and literatures, the obtained structures
were deduced as (9Z,12Z)-9,12-octadecanoic acid (3)










10 µg/mL 50 µg/mL 100 µg/
Figure 1 DPPH inhibition percent of the four sponges extracts.phthalic acid bis-[2-ethyl-hexyl] ester (6) [25] and trigly-
ceride fatty acid mixture (7) [26].
Biological study
The present results demonstrate the inhibitory effect of
different extracts of marine sponges, on antioxidant indi-
ces and carbohydrate hydrolyzing enzymes in vitro. The
2,2-diphenyl-1-picrylhydrazyl (DPPH)-free radical scav-
enging effects of different extracts from marine sponge
were shown in Table 1 and Figure 1. All the tested
extracts showed appreciable free radical scavenging activ-
ities. Extract of SP2 has the strongest radical scavenging
activity at different concentrations compared to other
extracts followed by SP3 and SP4. However, SP1 showed
the lowest radical scavenging activity. A dose–response
relationship was found in the DPPH radical scavenging
activity, at where the activity increased as the increase of
extracts concentrations. SP2 extract was able to reduce
the stable radical DPPH to the yellow color to give sig-
nificant inhibitory percent 47.7 ± 0.84, 60.53 ± 0.50,4 5
mL 500 µg/mL 1000 µg/mL LSD 5 %
Table 2 Inhibition percent of nitric oxide (NO) of the four sponges extracts
Concentrations Extracts of the four sponges
SP1 SP2 SP3 SP4
10 g/mL 10.30 ± 4.29c 37.60 ± 1.68e 15.26 ± 6.94d 13.50 ± 5.53d
50 μg/mL 16.92 ± 3.25c 39.16 ± 9.31d 24.94 ± 2.89c 21.41 ± 4.42c
100 μg/mL 21.95 ± 2.86b 52.13 ± 6.06c 33.30 ± 2.65bc 27.80 ± 4.32bc
500 μg/mL 23.59 ± 1.01b 56.58 ± 3.46b 36.29 ± 5.18ab 30.32 ± 2.74b
1000 μg/mL 36.14 ± 2.93a 53.85 ± 5.12a 44.64 ± 4.29a 41.24 ± 3.27a
LSD 5% 5.06 1.28 8.49 7.59
NO is expressed as%; data are mean ± SD of 3 replicates; statistical analysis is carried out using one way analysis of variance (ANOVA) using CoStat: computer
program; unshared superscript letters between treatments are significance values at P < 0.001.
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tions of 10, 50, 100, 500, and 1000 μg/mL, respectively.
Alternatively, SP3 showed a reducing inhibitory percent
of DPPH amounted 26.31 ± 0.50, 26.00 ± 1.38, 34.04 ±
0.94, 37.39 ± 1.10, and 40.17 ± 0.9% at the same concen-
trations of extracts, respectively. Moreover, SP4 showed a
significant reducing activity of 16.39 ± 4.63, 22.38 ± 1.23,
32.54 ± 1.42, 35.94 ± 1.42, and 38.48 ± 0.70%, respectively.
Contrarily, SP1 exhibited the lowest reducing activity
compared with aforementioned sponges extracts. The
demonstrated inhibitory activity of the DPPH by the
sponges extracts might be mainly attributed to their con-
taining of some terpenoidal analogs [26].
Nitric oxide synthase (NOS) is catalyzing the produc-
tion of nitric oxide (NO). Inducible NOS (iNOS) is
expressed by vascular endothelial cells and smooth
muscle cells in response to cytokines, unlike the two
other types of NOS, which are constitutive. NO pro-
duced by iNOS is implicated in inflammatory diseases








10 µg/mL 50 µg/mL 100 µg
Figure 2 Inhibition percent of NO of the four sponges extracts.different marine sponges extracts were illustrated in
Table 2 and Figure 2. The most reducing capacity was as
well considered for SP2, which showed significant ability
to reduce the activity of NO by 37.60 ± 1.68, 39.16 ±
9.13, 52.13 ± 6.06, 56.58 ± 3.46, and 53.85 ± 5.12% at con-
centrations of 10–1000 μg/mL. Alternatively, extract of
SP3 exhibited lower significant reducing activity of NO
(15.26 ± 6.94, 24.94 ± 2.89, 33.30 ± 2.65, 36.29 ± 5.18, and
44.64 ± 4.29%) with lower extent than those of SP2.
Based on the percentage scavenging values, it was
remarked that SP1 and SP4 exhibited moderate scaven-
ging effects with linear relationships in a dose-
dependent manner. Consequently, extracts of SP1 and
SP4 recorded potent reducing capability of 41.24 ± 3.27
and 38.17 ± 3.01%, respectively, at a concentration of
1000 μg/mL. Tasi et al. [28] reported that food and phy-
tochemicals exerts NO-suppressing activity via three dif-
ferent pathways: the blocking of iNOS expression,
inactivation of iNOS catalytic function, and the scaven-
ging NO. While NO suppressing effect was primarily4 5
/mL 500 µg/mL 1000 µg/mL LSD 5 %
Table 3 α-Amylase inhibition percent of four sponges extracts
Concentrations Extracts of the four sponges
SP1 SP2 SP3 SP4
10 μg/mL 7.41 ± 2.61e 92.00 ± 1.21 18.26 ± 3.97d 15.44 ± 2.68e
50 μg/mL 18.75 ± 2.04d 94.35 ± 2.69 24.55 ± 4.03c 21.72 ± 3.20d
100 μg/mL 24.27 ± 3.07c 85.22 ± 4.92 32.56 ± 2.07b 27.38 ± 1.73c
500 μg/mL 29.05 ± 1.47b 89.38 ± 8.22 37.14 ± 0.89ab 33.75 ± 2.31b
1000 μg/mL 38.13 ± 0.64a 88.40 ± 7.29 37.97 ± 1.86a 44.59 ± 1.55a
LSD 5% 3.9 NS 5.18 4.32
α-amylase is expressed as %; data are mean ± SD of 3 replicates; statistical analysis is carried out using one way analysis of variance (ANOVA) using CoStat:
computer program; unshared superscript letters between treatments are significance values at P < 0.001.
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extracts’ effects on the suppressing activity of NO pro-
duction might be attributed to their containing of poly-
phenolic compounds or the triterpenes [29].
In alternative manner, extracts of the four sponges
were tested against α-amylase carbohydrate hydrolyzing
enzyme activity (Table 3, Figure 3). The four sponges
showed potent α-amylase inhibitory activity, which may
be potentially useful in control of obesity and diabetes.
The inhibition of α-amylase by SP3 and SP4 was
remarked to be as dose dependent, exhibiting the high-
est significant reducing activity 44.59 ± 1.55 and 43.64
± 1.79%, respectively, at a concentration of 1000 μg/mL.
Furthermore, extract of SP2 exhibited the most dramatic
inhibiting effect at 10 and 50 μg/mL, displaying insignifi-
cant reducing activity 92.00 ± 1.21 and 94.35 ± 2.69%, re-












Figure 3 α-Amylase inhibition percent of four sponges extracts.recorded 88.40 ± 7.29% at 1000 μg/mL. Consequently,
SP3 recorded a significant inhibitory percent of 18.26
± 3.97, 24.55 ± 4.03, 32.56 ± 2.07, 37.14 ± 0.89, and 37.97
± 1.86% in a dose-dependent manner at 10, 50, 500, and
1000 μg/mL, respectively. The anti-amylase inhibitory
activity may be due to the ability of phenolic compounds
to interact with and/or inhibit proteins enzymes [30].
One therapeutic approach for treating diabetes is to
decrease the post-prandial hyperglycemia. This is done
by retarding the absorption of glucose through the
inhibition of the carbohydrate hydrolyzing enzymes α-
amylase, α-glucosidase, and β-galactosidase in the digest-
ive tract. Inhibition of these enzymes delay carbohydrate
digestion and prolong overall carbohydrate digestion
time, causing a reduction in the rate of glucose absorp-
tion and consequently blunting the post-prandial plasma
glucose rise [31]. Many natural resources have been4 5
LSD 5 %
Table 4 α-Glucosidase inhibition percent of the four sponges extracts
Concentrations Extracts of the four sponges
SP1 SP2 SP3 SP4
10 μg/mL 8.06 ± 3.51c 28.05 ± 1.63c 25.45 ± 4.04c 23.47 ± 4.56c
50 μg/mL 21.08 ± 4.68b 37.80 ± 2.55b 33.91 ± 3.15b 33.49 ± 1.76b
100 μg/mL 28.95 ± 1.44a 44.21 ± 2.87a 40.44 ± 4.34a 40.55 ± 3.08a
500 μg/mL 27.24 ± 3.45a 41.19 ± 1.59ab 37.42 ± 1.14ab 36.01 ± 1.78ab
1000 μg/mL 27.65 ± 2.37a 42.5 ± 2.24a 39.32 ± 2.60ab 38.11 ± 2.70ab
LSD 5% 5.97 4.14 5.93 5.93
β-galactosidase is expressed as %; data are mean ± SD of 3 replicates; statistical analysis is carried out using one way analysis of variance (ANOVA) using CoStat
computer program; unshared superscript letters between treatments are significance values at P < 0.001.
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sion of glucose. The inhibitory effects of the four
sponges extracts against α-glucosidase carbohydrate
hydrolyzing enzyme activity were further studied as
listed in Table 4 and Figure 4. Remarkable greater inhibi-
tory effects of SP2 (40.44 ± 4.34, 39.32 ± 2.60%) and SP3
(40.55 ± 3.08, 38.11 ± 2.70%) than SP1 (32.22 ± 3.96,
29.42 ± 0.62%) and SP4 (28.95 ± 1.44, 27.65 ± 2.37%)
were deduced at concentrations of 100 and 1000 μg/mL,
respectively. Hence, the inhibition percent was signifi-
cantly correlated with the increase in concentration of
inhibitors. The fact that α-glucosidase and α-amylase
showed different inhibition kinetics seemed to be due to
structural differences related to the origin of the enzymes
[32]. Manosroi et al. [33] attributed the anti-diabetic, anti-
inflammatory, anti-tumor, and anti-proliferative effect of
many species, to their constituents of mono, sesquiter-
penes, phenolic compounds, and flavonoids such as cin-
namic acid, caffeic acid, and rosmarinic acid.
β-Galactosidase inhibitory activity was finally studied











Figure 4 α-Glucosidase inhibition percent of the four sponges extractand Figure 5. Accordingly, SP2 and SP3 provided add-
itional support for the previous finding by having the
strongest reducing activity at various concentrations.
Hence, SP2 at 500 and 1000 μg/mL displayed signifi-
cantly the highest inhibitory percent amounted 67.82
± 3.94 and 66.86 ± 3.79%, respectively, followed by SP3
(62.63 ± 1.89 and 62.12 ± 4.37%, respectively) and SP4
(54.13 ± 2.44 and 55.08 ± 5.11%, respectively). In con-
trast, SP1 displayed a comparable insignificant inhibitory
activity of 45.89 ± 4.91, 43.77 ± 4.5% at 500 and 1000 μg/
mL, respectively. From the manipulated results, it was
deduced significant increase in reducing activity with
the increase in concentrations of the individual extract
(linear relationship).
Experimental
The NMR spectra were measured on Varian Unity 300
(300.145 MHz) and Varian Inova 600 (150.820 MHz)
spectrometers. ESI MS was recorded on a Thermo Finni-
gan LCQ with quaternary pump Rheos 4000 (Flux In-
strument); Thermo Scientific, USA). EI mass spectra4 5
LSD 5 %
s.
Table 5 β-galactosidase inhibition percent of four sponges extracts
Concentrations Extracts of the four sponges
SP1 SP2 SP3 SP4
10 μg/mL 11.45 ± 11.54b 51.35 ± 5.24b 23.09 ± 8.33b 17.24 ± 6.39c
50 μg/mL 31.58 ± 22.03ab 39.62 ± 8.53bc 34.78 ± 11.03b 35.35 ± 9.72b
100 μg/mL 27.37 ± 13.18ab 34.49 ± 11.82c 36.49 ± 8.35b 33.53 ± 11.38b
500 μg/mL 46.58 ± 8.22a 67.82 ± 3.94a 62.63 ± 1.89a 54.13 ± 2.44a
1000 μg/mL 42.21 ± 5.28a 66.86 ± 3.79a 62.12 ± 4.37a 55.08 ± 5.11a
LSD 5% 24.24 13.26 13.7 14.02
β-galactosidase is expressed as%; data are mean ± SD of 3 replicates; statistical analysis is carried out using one way analysis of variance (ANOVA) using CoStat
computer program; unshared superscript letters between treatments are significance values at P < 0.001.
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(70 eV); Thermo Scientific, USA. GC-MS was measured
on a Trace GC-MS Thermo Finnigan chromatograph,
ionization mode EI (70 eV), instrument equipped with a
capillary column CP-Sil 8 CB for amines (length: 30 m;
inside diameter: 0.25 mm; outside diameter: 0.35 mm;
film thickness: 0.25 μm); Thermo Scientific., USA. The
analysis was carried out at a programmed temperature:
initial temperature 40°C (kept for 1 min), then increasing
at a rate of 10°C/min and final temperature 280°C (kept
for 10 min), injector temperature was 250°C and detector
(mode of ionization: EI) temperature at 250°C, He was
used as carrier gas at a flow rate of 1 mL/min, total run
time 27 min, injection volume 0.2 μL. Flash chromatog-
raphy was carried out on silica gel (230–400 mesh). Rf
values were measured on Polygram SIL G/UV254 TLC
cards (Macherey-Nagel GmbH & Co. Germany). Size
exclusion chromatography was done on Sephadex LH-
20 (Lipophilic Sephadex, Amersham Biosciences Ltd.
(purchased from Sigma-Aldrich Chemie, Steinheim,









Figure 5 β-Galactosidase inhibition percent of four sponges extracts.were of analytical grade, which were purchased from
Sigma, Merck and Aldrich. All kits were the products of
Biosystems (Spain), Sigma Chemical Company (USA),
Biodiagnostic (Egypt).
Sponge materials, collection, and taxonomy
Four varieties of sponges belonging to the genus Sme-
nospongia (SP1, olieve, 0.75 kg-wet), Callyspongia (SP2,
faint brown, 0.42 kg-wet), Niphates (SP3, faint greenish
olieve, 0.15 kg-wet), and Stylissa (SP4,orange, 0.16 kg-
wet) were collected from two sites at Hurghada-coasts,
Red Sea, Egypt. The first site located north Hurghada at
El-Gouna, latitude N 27° 240 06.72″E 33° 410 13.52″ and
the second site is Shaa’b south Giffton island latitude N
27° 100 04.61″ E 33° 570 04.87″ (Figure 6). The sponge
samples were collected at depth of 5–8 m in September
of 2010 (Figure 7) and stored in a freezer until extrac-
tion. The four species were morphologically character-
ized by Mohamed A Ghani, and specimens of them were
deposited at Red Sea Marine parks, P.O. Box 363-Hur-
gada, Red Sea, Egypt.4 5
LSD 5 %
Figure 6 Red Sea satellite map show site locations of the collected sponges.
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the genus Smenospongia, family Thorectidae. Morpho-
logically, the SP1 is Massive with oscular mounds, display-
ing a bright to dark green coloration. The sponge exuded
abundant mucus when handled, exhibiting blunt ends of
primary protrude fibers on the surface [34,35]. The second
sponge was belonging to the genus Callyspongia and fam-
ily Callyspongiidae [36,37]. Morphologically, it showed
bluish to pinkish tubes and sticky massive. Moreover, tis-
sues of the sponge were clear away easily, leaving the clean
skeleton. They inhabit as well in the coral reef habitat
attached to corals or rocks. The third sponge was belong-
ing to the genus Niphates and family Niphatidae. Morpho-
logically, it is massive or encrusting, showing a bluish to
purplish grayish cushions and repent branches [36,37].
Finally, the fourth sponge was belonging to the genus
Stylissa and family Dictyonellidae [36,37]. Morphologic-
ally, it is bushy with orange color and tough consistency
(Figures 7 and 8).
Extraction and isolation
The four sponges, Smenospongia (SP1), Callyspongia
(SP2), Niphates (SP3) and Stylissa (SP4), wereindividually cut into small pieces and homogenized
mechanically (Figure 1), treated with DCM–MeOH (2:1)
and kept at approximately 5°C for 8 days. After filtration,
the DCM layers were extracted and evaporated in vacuo
to dryness affording 1.59, 0.57, 0.39, and 0.64 g from
sponges SP1, SP2, SP3, and SP4, respectively. In contrast
with sponges SP1 and SP3, both sponges SP2 and SP4
were applied to a series of chromatographic purifications
using silica gel, Sephadex, and PTLC affording no
desired and inadequate compounds amounts.
Working up and purification of smenospongia (SP1)
The afforded greenish-brown crude extract of sponge 1
(1.59 g) was subjected to silica gel (column 3 × 60 cm2)
and eluted with a cyclohexane-hexane/DCM/MeOH gra-
dient. Based on the TLC monitoring, visualized by UV
and spraying with anisaldehyde/sulfuric acid, five frac-
tions were obtained: FI (0.1 g), FII (0.2 g), FIII (0.3 g),
FIV (0.3 g), and FV (0.4). The fast oil fraction I was ap-
plied to GC-MS analysis, displaying a base signal (RT:
25.04 nm, 100%) of unknown component. Fraction II
was likely subjected to GC-MS analysis showing four sig-
nals representing four components (RT: 13.79, 100%),
SP4SP3 
SP1 SP2 
Figure 7 Photos of the collected four sponges (SP1, SP2, SP3, and SP4).
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of them were of unknown structures, while the last two
were assigned as di-isobutyl phthalate (1) and di-n-butyl
phthalate (2). TLC monitoring of the remaining fractions
(III, IV, and V) recognized their similarity, and they were
combined therefore (1.0 g). Consequently, the combined
fractions were then chromatographed on silica gel usingFigure 8 Macerated tissues of the collected four sponges (SP1, SP2, Scyclohexane-DCM–MeOH gradient and after monitor-
ing by TLC, six sub-fractions; PIa (80 mg), PIb (35 mg),
PIc (70 mg), PId (95 mg), PIe (38 mg), and PIf (27 mg).
An application of the sub-fractions to further purification
using Sephadex LH-20 (DCM/MeOH, 60:40) was carried
out. In accordance, sub-fractions PIa, PIc afforded a col-
orless semisolid of linoleic acid (3, 55 mg), whileP3, and SP4).
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of β-sitosterol (4, 27 mg). Purification of sub-fraction PId
afforded a colorless oil of an olefinic fatty acid (23 mg).
Similarly, purification sub-fraction PIe yielded a color-
less oil of an additional olefinic acid. Finally, an appli-
cation of the sub-fraction PIf to Sephadex LH-20 (DCM/
MeOH, 60:40) resulted in β-sitosterol (4, 3 mg) and
cholesterol (5, 3 mg).
Linoleic acid; (9Z,12Z)-9, 12-octadecanoic acid (3)
Colorless oil (55 mg) was detected as non-polar UV
absorbing band at 254 nm and stained to blue when
sprayed by anisaldehyde/sulfuric acid and heated. –
C18H32O2 (280). –Rf = 0.90 (CHCl3/MeOH, 10%). -
1 H
NMR (CDCl3, 300 MHz): δ = 8.98 (s, br, 1 H, COOH),
5.43–5.28 (m, 4 H, 9,10,12,13-CH), 2.78 (t, 3 J = 6.0 Hz,
2 H, 11-CH2), 2.38 (t,
3 J = 7.2 Hz, 2 H, 2-CH2), 2.08 (m,
4 H, 8,14-CH2), 1.63 (m, 2 H, 3-CH2), 1.42–1.23 (m,
14 H, 4,5,6,7,16,17-CH2), 0.85 (m, 3 H, 18-CH3). –
13 C/
APT NMR (CDCl3, 50 MHz): δ = 180.1 (CO, Cq), 130.1
(CH-13), 129.9 (CH-9), 128.0 (CH-10), 127.8 (CH-12),
31.5 (CH2-2), 29.6 (CH2-16), 29.6 (CH2-11), 29.5 (CH2-
14), 29.3 (CH2-8), 29.1 (CH2-7), 29.0 (CH2-6), 29.0
(CH2-5), 27.1 (CH2-4), 25.6 (CH2-3), 24.7 (CH2-15), 22.5
(CH2-17) 14.0 (CH2-18). –EI MS (70 eV): m/z (%) = 280
(80), 264 (28), 137 (10), 124 (15), 110 (28), 95 (60), 81
(84), 67 (100), 55 (92), 41 (92).
β-sitosterol (4)
Colorless solid, UV non-absorbing, turned blue on
spraying with anisaldehyde/sulfuric. –C29H50O (414). –
Rf = 0.51(CH2Cl2/CH3OH 9: 0.5). –
1 H NMR (CDCl3,
300 MHz): δ = 5.36 (d, J = 4.7 Hz, 1 H, H-6), 3.53 (m,
1 H, H-3), 2.36–2.21 (m, 4 H, H2-1, H2-4), 2.01–1.93 (m,
2 H, H2-6), 1.85–1.75 (m, 4 H), 1.58–1.43 (m, 5 H),
1.21–1.03 (m, 14 H), 0.99 (s, 3 H, CH3-19), 0.94 (d, 3 H,
J = 6.1 Hz, CH3-21), 0.86 (d, 3 H, J = 6.2 Hz, CH3-26),
0.84 (d, 3 H, J = 6.2 Hz, CH3-27), 0.79 (t, 3 H, J = 6.7,
CH3-29), 0.67 (s, 3 H, CH3-18). –EI-MS (70 eV): m/z
(%) = 414 ([M]+, 100), 396 ([M-H2O]
+, 37), 381 (21), 329
(34), 303 (41), 283 (16), 259 (10), 241 (22), 227 (9), 206
(11), 189 (18), 173 (22), 151 (13), 135 (25), 123 (21), 109
(18), 83 (13), 43 (15).
Cholesterol (5)
Colorless solid, UV non-absorbing, turned blue on spray-
ing with anisaldehyde/sulfuric. –C27H46O (386). –Rf =
0.47(CH2Cl2/CH3OH 9:0.5). –
1 H NMR (CDCl3,
300 MHz): δ = 5.37 (d, J = 4.7 Hz, 1 H, H-6), 3.51 (m, 1 H,
H-3), 2.35–2.19 (m, 4 H, H2-1, H2-4), 2.02–1.94 (m, 2 H,
H2-6), 1.85–1.75 (m, 4 H), 1.58–1.43 (m, 6 H), 1.18–1.02
(m, 12 H), 0.99 (s, 3 H, CH3-19), 0.94 (d, 3 H, J = 6.1 Hz,
CH3-21), 0.86 (d, 3 H, J = 6.2 Hz, CH3-26), 0.84 (d, 3 H, J
= 6.2 Hz, CH3-27), 0.67 (s, 3 H, CH3-18). –
13 C NMR(CDCl3, 75 MHz): δ = 42.7 (Cq, C-13), 36.7 (CH, C-1),
140.6 (Cq, C-5), 56.4 (CH, C-14), 50.2 (CH, C-9), 31.8
(CH, C-8), 56.3 (CH, C-17) 121.8 (CH, C-6), 40.0 (CH2,
C-24), 32.0 (CH2, C-16), 21.0 (CH2, C-11), 24.3 (CH2, C-
15), 37.3 (Cq, C-10), 28.2 (CH, C-25), 42.3 (Cq, C-4), 35.9
(CH2, C-12), 12.1 (CH3, C-18), 31.7 (CH2, C-7), 31.2
(CH2, C-2), 71.5 (CH, C-3), 19.4 (CH3, C-19), 24.0 (CH2,
C-23), 36.3 (CH2, C-22), 18.8 (CH3, C-21), 35.8 (CH, C-
20), 22.6 (CH3, 26), 22.6 (CH3, 27). –EI-MS (70 eV): m/z
(%) = 386 ([M]+, 100), 368 ([M-H2O]
+, 36), 353 (20), 301
(32), 275 (40), 255 (18), 231 (12), 213 (21), 199 (8), 178
(12), 161 (16), 145 (21), 133 (12), 107 (24), 95 (20), 81
(17), 55 (14), 43 (16).
Working up and purification of callyspongia (SP3)
The afforded reddish-brown crude extract of sponge 3
(0.39 g) was subjected to silica gel column (2 × 50 cm)
and eluted with a cyclohexane-hexane/DCM/MeOH
gradient. According to TLC monitoring, visualized by
UV and spraying with anisaldehyde/sulfuric acid, three
fractions were obtained: FIa (140 mg), FIb (70 mg), and
FIc (60 mg). Purification of FIa using Sephadex LH-20
(DCM/MeOH, 60:40) afforded a colorless oil of phthy-
lester (6, 80 mg). Purification of FIb by Sephadex LH-20
(DCM/MeOH, 60:40) resulted in a colorless oil of trigly-
ceride fatty acid ester mixture (7, 35 mg). An application
of fraction FIc to purification with Sephadex LH-20
(DCM/MeOH, 60:40) afforded a colorless solid of chol-
esterol (5, 28 mg).
Di-(2-ethylhexyl)phthalate(DEHP)(6)
UV-absorbing (254 nm) turned intensive violet on spray-
ing with anisaldehyde/sulfuric acid after heating, and
changed latter as blue. –C24H38O4 (390). –Rf = 0.90;
CHCl3. –
1 H NMR (CDCl3, 300 MHz): δ = 7.70 (m, 2 H),
7.50 (m, 2 H), 4.25 (d, 3 J = 5 Hz, 2 H), 1.80–1.20 (br m,
18 H), 1.00–0.75 (br m, 12 H). –13 C NMR (CDCl3,
75 MHz): δ = 167.7 (Cq-10,1″), 132.4 (Cq-1,2), 130.9 (CH-
3,6), 128.8 (CH-4,5), 68.1 (CH2-20, 2″), 38.7 (CH-30,3″),
30.3 (CH2-40,4″), 28.9 (CH2-50,5″), 22.9 (CH2-60,6″), 14.0
(CH3-70,7″), 23.7 (CH2-80,8″), 10.9 (CH3-90,9″). –EI-MS
(70 eV): m/z: 390 (3), 279 (20), 149 (64). –CI-MS (NH3):
798 ([2 M +NH4]
+, 62 %), 408 ([M +NH4]
+, 100), 391
([M +H]+, 65).
Triglyceride fatty acids mixture (7)
Colorless oil, turned violet by anisaldehyde/sulfuric acid;
–Rf = 0.78 (CH2Cl2). –
1 H NMR (300 MHz, CDCl3): δ =
5.37 (m, 2 H), 5.34 (m 2 H), 5.27 (m, 1 H), 4.30 (dd, 2 H,
J = 11.9, 4.3 Hz), 4.14 (dd, 2 H, J = 11.9, 6.0 Hz), 2.81 (m,
2 H), 2.31 (m, 2 H), 2.02 (m, 4 H), 1.61 (m, 2 H), 1.40–
1.20 (m, 22 H), and 0.88 (t, 9 H, J = 6.9 Hz). –13 C NMR
(75 MHz, CDCl3): δ = 172.9 (2Cq, CO), 172.5 (Cq, CO),
129.5 (2CH), 129.1 (2CH), 132–127 (further mCH), 68.8
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29.7 (CH2) 29.6 (CH2) 29.5 (CH2) 29.4 (CH2) 29.3 (CH2)
29.2 (CH2) 29.0 (CH2) 29.1 (CH2), 29.0 (CH2), 27.2 (CH2),
25.6 (CH2), 24.9 (CH2), 22.7 (CH2) and 14.1 (CH3).
In vitro antioxidant study
Purified enzymes
Carbohydrate metabolizing enzymes; α-amylase, α-glu-
cosidase, and β-galactosidase (EC3.2.1.1, EC3.2.1.20, and
EC3.2.1.23, respectively) were obtained from Sigma
Chemical Company (USA).
The antioxidant scavenging activity
The activity of serial concentrations of different sponge
extracts (10:1000 μg/mL) on DPPH-free radical will per-
formed according to the method of McCue et al. [36]
and Katsube et al. [37]. The decrease in optical density
of DPPH- is calculated compared with a control sub-
stance as follows:
%Inhibition ¼ Acontrol  Asample  100
Determination of NO-free radical scavenging activity
NO-scavenging activity of extracts was determined
according to the method of Sreejayan and Rao [16].
Determination of α-amylase
α-Amylase was determined according to the method of
Bernfeld [38].
Determination of β-galactosidase activity
β-galactosidase was measured by the method of Sánchez
and Hardisson [39].
Estimation of α-glucosidase activity
α-glucosidase activity was determined according to the
method of Kapustka et al. [40] and Kim et al. [32].
Conclusions
In conclusion, this study was performed to investigate the
effects of the extracts of four marine sponges on some bio-
chemical parameters including antioxidant and three differ-
ent carbohydrate hydrolyzing enzymes (α-amylase, β-
galactosidase, and α-glucosidase). These sponges were col-
lected from Red Sea at Egyptian coasts, which were taxo-
nomically belonged to the genus of Smenospongia (SP1),
Callyspongia (SP2), Niphates (SP3), and Stylissa (SP4). The
results demonstrated that different extracts exhibited in-
hibitory effects on oxidative stress indices and carbohy-
drate hydrolyzing enzymes in linear relationships to some
extent with concentration of inhibitors (dose dependant).
The extracts of sponges (3, 1, and 2) showed, respectively,
potent-reducing power. Chemical characterizations ofsponges SP1 and SP3 were discussed, at where di-isobutyl
phthalate (1), di-n-butyl phthalate (2), linoleic acid (3),
β-sitosterol (4), and cholesterol (5) were obtained from
sponge SP1; while sponge SP3 produced bis-[2-ethyl]-
hexyl-phthylester (6) and triglyceride fatty acid ester (7).
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